CGON – cg oncology, inc. - common stock (US:NASDAQ)
Stock Stats
News
CG Oncology (NASDAQ:CGON) had its price target raised by analysts at Truist Financial Corporation from $66.00 to $75.00. They now have a "buy" rating on the stock.
CG Oncology (NASDAQ:CGON) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
CG Oncology (NASDAQ:CGON) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
CG Oncology: 'Strong Buy' On Earlier Than Expected Completed Recruitment Cretostimogene [Seeking Alpha]
CG Oncology (CGON) Is Up 29.7% After Accelerating PIVOT-006 Phase 3 Timeline - Has The Bull Case Changed? [Yahoo! Finance]
Form 8-K CG Oncology, Inc. For: Jan 13
Form 424B5 CG Oncology, Inc.
Form 4 CG Oncology, Inc. For: Jan 09 Filed by: Mulay James
Form 144 CG Oncology, Inc. Filed by: Mulay James
Form 8-K CG Oncology, Inc. For: Jan 09
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.